Literature Citations Close

Literature Citations for OriGene shRNA representing Locus_ID 3717


Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements, Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter, and Nicholas C.P. Cross, Haematologica, Mar 2013; 98: 404 - 408.

A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway, Ying Zheng, Hongwei Qin, Stuart J. Frank, Luqin Deng, David W. Litchfield, Ayalew Tefferi, Animesh Pardanani, Fang-Tsyr Lin, Jingzhi Li, Bingdong Sha, and Etty N. Benveniste, Blood, Jul 2011; 118: 156 - 166.